norovirus and glp 1 GLP-1 the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1 receptor agonists are increasingly

Article Title : [Not specified in the provided content] News Publication Date : [Not specified in the provided content] Web References : doi:10.1001/jamahealthforum.2025.4258 Keywords : Peptides, Agonists, Cohort studies, Racial differences, Ethnicity, Medications, Pharmaceuticals, Health care costs, Health insurance Tags: chronic disease management inequalitieseconomic factors in medication adherenceGLP-1 receptor agonists prescription disparitiesglycemic control and weight managementhealthcare equity in pharmaceutical accessmedication adherence in type 2 diabetesnon-Hispanic Black and Hispanic health disparitiesout-of-pocket costs for diabetes medicationspolicy implications for diabetes careprescription fill rates by demographicrace and ethnicity in diabetes treatmentsystemic barriers in healthcare access

2 at $4.19 on news the U.S

A Randomized Pilot Study of Dietary Treatments for Polycystic Ovary Syndrome in Adolescents

Generic semaglutide would come to market under the pan-Canadian Pharmaceutical Alliance's tiered pricing framework

Saxendas black box warns of the risk of these tumors

PMID: 36151309